Uploaded on Mar 8, 2024
According to the latest research report by IMARC Group, The global 3D printing in healthcare market size reached US$ 3.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.4 Billion by 2032, exhibiting a growth rate (CAGR) of 13.2% during 2024-2032. More Info:- https://www.imarcgroup.com/3d-printing-in-healthcare-market
3D Printing in Healthcare Market Growth, Demand and Challenges of the Key Industry Players 2024-32
Global 3D Printing in Healthcare Market Research and Forecast Report 2024-2032 Format: PDF+EXCEL © 2023 IMARC All Rights Reserved About IMARC Group In ternat ional Market Analys is Research and Consul t ing Group is a leading adv iser on management s t rategy and market research wor ldwide. We par tner wi th c l ients in a l l regions and indust ry vert ica ls to ident i fy thei r h ighest -value oppor tuni t ies, address thei r most cr i t ica l chal lenges, and t ransform thei r bus inesses. IMARC’s in format ion products inc lude major market , sc ient i f ic , economic and technological developments for bus iness leaders in pharmaceut ica l , indust r ia l , and h igh technology organizat ions. Market forecasts and indust ry analys is for b iotechnology, advanced mater ia ls , chemicals , food and beverage, t ravel and tour ism, nanotechnology and novel process ing methods are at the top of the company’s exper t ise. IMARC’s ta i lored approach combines unfathomable ins ight in to the dynamics o f companies and markets wi th c lose cooperat ion at a l l levels of the c l ient organizat ion. This ensures that our c l ients achieve unmatchable compet i t ive advantage, bui ld more pro f ic ient organizat ions, and secure las t ing resul ts . A c c o r d i n g t o t h e l a t e s t r e p o r t b y IM A R C G r o u p , t i t l e d " 3 D P r in t i n g in H e a l t h c a r e M a r k e t : G lo b a l I n d u s t r y T r e n d s , S h a r e , S i z e , G r o w t h , O p p o r t u n i t y a n d F o r e c a s t 2 0 2 4 - 2 0 3 2 , " t h e g l o b a l 3 D p r i n t i n g i n h e a l t h c a r e m a r k e t s i z e r e a c h e d U S $ 3 .0 B i l l i o n i n 2 0 2 3 . 3 D p r i n t i n g , a l s o k n o w n a s a d d i t i v e m a n u f a c tu r i n g , r e f e r s t o t h e p r o c e s s o f m a k i n g s o l i d Report t h r e e - d i m e n s i o n a l o b j e c t s . I t i s c o m m o n l y u s e d i n t h e h e a l t h c a r e s e c t o r t o c r e a t e n e w s u r g i c a l c u t t i n g d r i l l g u i d e s , p r o s t h e t i c s , a n d p a t i e n t - s p e c i f i c r e p l i c a s o f b o n e s , o r g a n s , a n d b l o o d v e s s e l s . I t f a c i l i t a t e s t h e c u s t o m i z a t i o n a n d p e r s o n a l i z a t i o n o f m e d i c a l Highlight and p r o d u c t s , d r u g s , a n d e q u i p m e n t a n d a s s i s t s i n p r o d u c i n g l i v i n g h u m a n c e l l s o r t i s s u e i n r e g e n e r a t i v e m e d i c i n e a n d t i s s u e e n g i n e e r i n g . I t h e l p s m i n i m i z e o p e r a t i v e r i s k s i n v o l v e d d u r i n g c o m p l e x m e d i c a l p r o c e d u r e s , l o w e r s t h e Description c h a n c e s o f i n f e c t i o n s , a n d r e d u c e s t h e d u r a t i o n o f a n e s t h e s i a e x p o s u r e . I t a l s o a i d s i n s a v i n g t i m e , d e c r e a s i n g c o s t s , a n d e n a b l i n g f a s te r a n d m o r e e f f e c t i v e d e l i v e r y o f m e d i c a l s e r v i c e s . A s a r e s u l t , 3 D p r i n t i n g i n h e a l t h c a r e h a s g a i n e d i m m e n s e t r a c t i o n a c r o s s t h e g l o b e f o r m a n u f a c t u r i n g c u s t o m i z e d p r o s th e t i c s , i m p l a n t s , a n d o th e r w e a r a b l e d e v i c e s . R e q u e s t f o r a P D F s a m p le o f t h is r e p o r t : h t t p s : / / w w w . i m a r c g r o u p . c o m /3 d - p r i n t i n g - i n - h e a l t h c a r e - m a r k e t / r e q u e s t s a m p l e Report Description G l o b a l 3 D P r i n t i n g i n H e a l t h c a r e M a r k e t T r e n d s : T h e r i s i n g p r e f e r e n c e s f o r c u s t o m i z e d m e d i c a l p r o d u c t s a n d t h e s u r g i n g p o p u l a r i t y o f p r e c i s i o n m e d i c i n e r e p r e s e n t t h e p r i m a r y f a c t o r s d r i v i n g t h e m a r k e t g r o w t h . B e s i d e s t h i s , t h e i n c r e a s i n g i n c i d e n c e s o f c h r o n i c d i s e a s e s , s u c h a s c a n c e r a n d r e s p i r a t o r y a n d c a r d i o v a s c u l a r d i s o r d e r s ( C V D s ) , a r e o t h e r m a j o r g r o w t h - i n d u c i n g f a c t o r s . A d d i t i o n a l l y , t h e r e i s a r i s e i n t h e u s e o f 3 D p r i n t i n g i n l i v e r m o d e l i n g a n d t h e d e v e l o p m e n t o f t i s s u e , b o n e , a n d m e d i c a l i m p l a n t s . I n l i n e w i t h t h i s , t h e e s c a l a t i n g d e m a n d f o r r e g e n e r a t i v e m e d i c i n e s , s t e m c e l l s o l u t i o n s , a n d c a n c e r t h e r a p e u t i c s h a s c a t a l y z e d m a r k e t g r o w t h . A p a r t f r o m t h i s , t h e g r o w i n g u s a g e o f t e c h n o l o g i c a l l y a d v a n c e d p r o d u c t s f o r p a t i e n t m o n i t o r i n g a n d d i s e a s e m a n a g e m e n t t o i m p r o v e p a t i e n t c a r e q u a l i t y a n d r e d u c e t h e c o s t o f c a r e h a s a u g m e n t e d t h e d e m a n d f o r 3 D p r i n t i n g i n h e a l t h c a r e . F u r t h e r m o r e , t h e r i s i n g p u b l i c a n d p r i v a t e f u n d i n g t o e x p a n d 3 D p r i n t i n g m a n u f a c t u r i n g c a p a b i l i t i e s h a v e p r o p e l l e d t h e m a r k e t g r o w t h . A l o n g w i t h t h i s , c o n t i n u a l t e c h n o l o g i c a l a d v a n c e m e n t s i n 3 D p r i n t e r s a n d h e a v y i n v e s t m e n t s i n a g g r e s s i v e p r o m o t i o n a l a c t i v i t i e s a n d m a r k e t i n g c a m p a i g n s b y k e y p l a y e r s a r e c o n t r i b u t i n g t o m a r k e t g r o w t h . O t h e r f a c t o r s , i n c l u d i n g t h e e x p a n d i n g g e r i a t r i c p o p u l a t i o n , i n c r e a s i n g b i o m e d i c a l a n d p h a r m a c e u t i c a l a p p l i c a t i o n s , e a s y a v a i l a b i l i t y o f b i o p r i n t i n g t i s s u e s a n d o r g a n s , a n d o n g o i n g r e s e a r c h a n d d e v e l o p m e n t ( R & D ) a c t i v i t i e s , a r e a l s o p r o v i d i n g a p o s i t i v e t h r u s t t o t h e m a r k e t g r o w t h . L o o k i n g f o r w a r d , I M A R C G r o u p e x p e c t s t h e m a r k e t v a l u e t o r e a c h U S $ 9 . 4 B i l l i o n b y 2 0 3 2 , g r o w i n g a t a C A G R o f 1 3 . 2 % d u r i n g 2 0 2 4 - 2 0 3 2 . V i e w R e p o r t T O C , F i g u r e s a n d T a b l e s : h t t p s : / / w w w . i m a r c g r o u p . c o m / 3 d - p r i n t i n g - i n - h e a l t h c a r e - m a r k e t Breakup by Material: • Polymer • Metals • Ceramic • Organic Breakup by Technology: Report • Droplet Depos it ion o Fused Fi lament Fabr icat ion (FFF) Segmentation Technology o Low-temperature Deposi t ion Manufactur ing (LDM) o Mult iphase Jet So l id ifi cat ion (MJS) • Photopolymer izat ion o Stereol i thography (SLA) o Cont inuous L iqu id Interface Product ion (CL IP) o Two-photon Polymer izat ion (2PP) • Laser Beam Melt ing o Select ive Laser S inter ing (SLS) o Select ive Laser Melt ing (SLM) o Direct Metal Laser Sinter ing (DMLS) • Electronic Beam Melt ing (EBM) • Laminated Object Manufacturing • Others Report Segmentation Breakup by Application: • External Wearable Devices o Hearing Aids o Prosthesis and Orthot ics o Dental Products • Cl in ical Study Devices o Drug Test ing o Anatomical Models • Implants o Surgical Guides o Cranio -maxi l lofac ial Implants o Orthopedic Implants • Tissue Engineer ing Breakup by End User: Report • Medical and Surg ical Centers Segmentation • Pharmaceutical and Biotechnology Companies • Academic Inst i tut ions Breakup by Region: • North America • Asia-Pacifi c • Europe • Lat in America • Middle East and Afr ica • 3D Systems Inc. • Desktop Metal Inc. • EOS GmbH Competitive • Formlabs • Material ise NV Landscape • Organovo Holding Inc. with Key • Oxford Performance Materials Inc. Players • Prodways Tech • Proto Labs Inc. • Renishaw plc • SLM Solutions Group AG • Stratasys Ltd What was the size of the global 3D printing in healthcare market in 2023? What is the expected growth rate of the global 3D printing in healthcare market during 2024-2032? Key What are the key factors driving the global 3D printing in healthcare market? Questions What has been the impact of COVID-19 on the Answered in global 3D printing in healthcare market? the Report What is the breakup of the global 3D printing in healthcare market based on the material? What is the breakup of the global 3D printing in healthcare market based on the technology? What is the breakup of the global 3D printing in healthcare market based on the application? What is the breakup of the global 3D printing in healthcare market based on the end user? Key What are the key regions in the global 3D printing in healthcare market? Questions Answered in Who are the key players/companies in the global 3D printing in healthcare market? the Report 1 P r e f a c e 2 S c o p e a n d M e t h o d o l o g y 2 . 1 O b j e c t i v e s o f t h e S t u d y 2 . 2 S t a k e h o l d e r s 2 . 3 D a t a S o u r c e s 2 . 3 . 1 P r i m a r y S o u r c e s 2 . 3 . 2 S e c o n d a r y S o u r c e s 2 . 4 M a r k e t E s t i m a t i o n Table of 2 . 4 . 1 B o t t o m - U p A p p r o a c h 2 . 4 . 2 T o p - D o w n A p p r o a c h 2 . 5 F o r e c a s t i n g M e t h o d o l o g y 3 E x e c u t i v e S u m m a r y 4 I n t r o d u c t i o n Contents 4 . 1 O v e r v i e w 4 . 2 K e y I n d u s t r y T r e n d s5 G l o b a l 3 D P r i n t i n g i n H e a l t h c a r e M a r k e t 5 . 1 M a r k e t O v e r v i e w 5 . 2 M a r k e t P e r f o r m a n c e 5 . 3 I m p a c t o f C O V I D - 1 9 5 . 4 M a r k e t F o r e c a s t 6 M a r k e t B r e a k u p b y M a t e r i a l 6 . 1 P o l y m e r 6 . 1 . 1 M a r k e t T r e n d s 6 . 1 . 2 M a r k e t F o r e c a s t 6 . 2 M e t a l s 6 . 2 . 1 M a r k e t T r e n d s 6 . 2 . 2 M a r k e t F o r e c a s t 6 . 3 C e r a m i c 6 . 3 . 1 M a r k e t T r e n d s 6 . 3 . 2 M a r k e t F o r e c a s t 6 . 4 O r g a n i c 6 . 4 . 1 M a r k e t T r e n d s 6 . 4 . 2 M a r k e t F o r e c a s t 7 M a r k e t B r e a k u p b y T e c h n o l o g y 7 . 1 D r o p l e t D e p o s i t i o n 7 . 1 . 1 M a r k e t T r e n d s 7 . 1 . 2 K e y S e g m e n t s 7 . 1 . 2 . 1 F u s e d F i l a m e n t F e b r i c a t i o n ( F F F ) T e c h n o l o g y 7 . 1 . 2 . 2 L o w - t e m p e r a t u r e D e p o s i t i o n M a n u f a c t u r i n g ( L D M ) 7 . 1 . 2 . 3 M u l t i f a c e J e t S o l i d i f i c a t i o n ( M J S ) Table of 7 . 1 . 3 M a r k e t F o r e c a s t 7 . 2 P h o t o p o l y m e r i z a t i o n 7 . 2 . 1 M a r k e t T r e n d s 7 . 2 . 2 K e y S e g m e n t s Contents 7 . 2 . 2 . 1 S t e r e o l i t h o g r a p h y ( S L A ) 7 . 2 . 2 . 2 C o n t i n u o u s L i q u i d I n t e r f a c e P r o d u c t i o n ( C L I P ) 7 . 2 . 2 . 3 T w o - p h o t o n P o l y m e r i z a t i o n ( 2 P P ) 7 . 2 . 3 M a r k e t F o r e c a s t 7 . 3 L a s e r B e a m M e l t i n g 7 . 3 . 1 M a r k e t T r e n d s 7 . 3 . 2 K e y S e g m e n t s 7 . 3 . 2 . 1 S e l e c t i v e L a s e r S i n t e r i n g ( S L S ) 7 . 3 . 2 . 2 S e l e c t i v e L a s e r M e l t i n g ( S L M ) 7 . 3 . 2 . 3 D i r e c t M e t a l L a s e r S i n t e r i n g ( D M L S ) 7 . 3 . 3 M a r k e t F o r e c a s t 7 . 4 E l e c t r o n i c B e a m M e l t i n g ( E B M ) 7 . 4 . 1 M a r k e t T r e n d s 7 . 4 . 2 M a r k e t F o r e c a s t F o r m o r e i n f o r m a t i o n , v i s i t : ht t ps : / /w ww. i ma rc gro up . c o m /3 d -p r i n t i ng - i n -hea l thc a re -m a rke t / t o c Disclaimer © 2023 IMARC Al l R ights Reserved Th is Pub l i ca t ion and a l l i t ’ s con ten ts un less o therw ise men t i oned a re copy r i gh ted in the name o f I n t e rna t i ona l Marke t Ana lys i s Research and Consu l t ing ( IMARC) . No pa r t o f t h i s pub l i ca t ion may be rep roduced , repackaged , red i s t r i bu ted o r res o ld i n who le o r i n any pa r t . The pub l i ca t ion may a l so no t be used i n any f o rm o r by and means g raph i c e lec t ron ic o r mechan ic a l , i nc lud ing pho tocopy ing , reco rd ing , t ap ing o r by i n fo rmat i on s to rage o r re t r ieva l , o r by any o the r f o rm, w i t hou t the exp ress c ons en t o f I n t e rna t iona l Marke t Ana lys i s Research and Consu l t i ng ( IMARC) . Disc la imer : Al l con ten ts and da ta o f t h i s pub l i c a t i on , i nc lud ing fo recas t s , da ta ana lys i s and op in ion have been based on in f o rmat ion and sources be l ieved to be accu ra te and re l iab le a t t he t ime o f pub l i sh ing . In t e rna t i ona l Ma rke t Ana l ys is Research and Consu l t ing makes no rep resen ta t ion o f war ran t y o f any k ind as to t he acc u racy o r comp le teness o f any I n fo rmat i on p rov ided . IMARC accep ts no l i ab i l i t y wha tsoever f o r any los s o r damage resu l t i ng f rom op in ion , e r ro rs o r i naccu rac ies i f any f ound th is pub l i ca t ion . IMARC, IMARC Group and G loba l Therapy I ns igh t Ser i es a re reg is t e red t rademarks o f I n te rna t iona l Marke t Ana lys i s Research and Consu l t ing . A l l o the r t rademarks used i n th i s pub l i ca t i on a re reg i s te red t rademarks o f t he i r r espec t i ve compan ies . Contact Us Visit us at : https://www.imarcgroup.com TELEPHONE: +1-631-791-1145 E-MAIL: [email protected]
Comments